Journal of Neuroimmunology
Volume 229, Issue 1 , Pages 107-111 , 15 December 2010

A novel galectin-1 and interleukin 2 receptor β haplotype is associated with autoimmune myasthenia gravis

  • Zsuzsanna Pál

      Affiliations

    • Center for Molecular Neurology, Department of Neurology, Semmelweis University, Budapest, Hungary
    • Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
    • ,
  • Péter Antal

      Affiliations

    • Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
    • ,
  • András Millinghoffer

      Affiliations

    • Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
    • ,
  • Gábor Hullám

      Affiliations

    • Department of Measurement and Information Systems, Budapest University of Technology and Economics, Budapest, Hungary
    • ,
  • Krisztina Pálóczi

      Affiliations

    • Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
    • ,
  • Sára Tóth

      Affiliations

    • Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
    • ,
  • Hans-Joachim Gabius

      Affiliations

    • Institute of Physiological Chemistry, Faculty of Veterinary Medicine, Ludwig-Maximilians-University Munich, Munich, Germany
    • ,
  • Mária Judit Molnár

      Affiliations

    • Center for Molecular Neurology, Department of Neurology, Semmelweis University, Budapest, Hungary
    • ,
  • András Falus

      Affiliations

    • Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
    • Research Group for Inflammation Biology and Immunogenomics, Hungarian Academy of Sciences, Budapest, Hungary
    • ,
  • Edit Irén Buzás

      Affiliations

    • Department of Genetics, Cell and Immunobiology, Semmelweis University, Budapest, Hungary
    • Corresponding Author InformationCorresponding author. Department of Genetics, Cell and Immunbiology, Semmelweis University, Nagyvárad tér 4., Budapest, Hungary. Tel./fax: +36 1 210 2930.

Received 16 April 2010 ,Revised 21 May 2010 ,Accepted 19 July 2010.

References 

  1. André S, Sanchez-Ruderisch H, Nakagawa H, Buchholz M, Kopitz J, Forberich P, et al. Tumor suppressor p16INK4a: modulator of glycomic profile and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells. FEBS J. 2007;274:3233–3256
  2. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324
  3. Bardosi A, Dimitri T, Wosgien B, Gabius H-J. Expression of endogenous receptors for neoglycoproteins, especially lectins, which allow fiber typing on formaldehyde-fixed, paraffin embedded muscle biopsy specimens. A glycohistochemical, immunohistochemical and glycobiochemical study. J. Histochem. Cytochem. 1989;37:989–998
  4. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21(2):263–265
  5. Barton A, Thomson W, Ke X, Eyre S, Hinks A, Bowes J, et al. Identification of novel RA susceptibility loci at chromosomes 10p15, 12q13 and 22q13. Nat. Genet. 2008;40(10):1156–1159
  6. Donnelly P, Stephens M. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. Soc. Hum. Genet. 2003;73(5):1162–1169
  7. Dunn KL, Davie JR. The many roles of the transcriptional regulator CTCF. Biochem. Cell Biol. 2003;81(3):161–167
  8. Earl LA, Bi S, Baum LG. N- and O-glycans modulate galectin-1 binding, CD45 signaling, and T-cell death. J. Biol. Chem. 2010;285(4):2232–2244
  9. Fuertes MB, Molinero LL, Toscano MA, Ilarregui JM, Rubinstein N, Fainboim L, et al. Regulated expression of galectin -1 during T cell activation involves Lck and Fyn kinases and signaling through MEK1/ERK, p38 MAP kinase and p70S6 kinase. Mol. Cell. Biochem. 2004;267:177–185
  10. Giraud M, Vandiedonck C, Garchon H-J. Genetic factors in autoimmune myasthenia gravis. PNAS. 2008;1132:180–192
  11. Gombert WM, Krumm A. Targeted deletion of multiple CTCF-binding elements in the human c-myc gene reveals a requirement for CTCF in c-myc expression. PloS One. 2009;4(7):e6109
  12. Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, et al. Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell. 2007;128(6):1231–1245
  13. Levi G, Tarrab-Hazdai R, Teichberg VI. Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits. Eur. J. Immunol. 1983;13:500–507
  14. Molnar MJ, Bencsik P. Establishing a neurological–psychiatric biobank: banking, informatics, and ethics. Cell Immun. 2006;244:101–104
  15. Rotblat B, Niv H, André S, Kaltner H, Gabius H-J, Kloog Y. Galectin-1 (L11A) predicted from a computed galectin-1 farnesyl-binding pocket selectively inhibits Ras-GTP. Cancer Res. 2004;64(9):3112–3118
  16. Salvatore P, Contursi C, Benvenuto G, Bruni CB, Chiariotti L. Characterization and functional dissection of the galectin-1 gene promoter. FEBS Lett. 1995;373:159–163
  17. Schwartz-Albiez R. Inflammation and glycosciences. In:  Gabius H-J editors. The Sugar Code Fundamentals of Glycosciences. Weinheim, Germany: Wiley VHC; 2009;p. 447–467
  18. Sewry CA, Molnar MJ. Histopathology and immunoanalysis of muscle. In:  Karpati G,  Hilton-Jones D,  Bushby K,  Griggs RC editor. Disorders of Voluntary Muscle Camebridge. 8:UK: Camebridge University Press; 2010;p. 93–127Edition
  19. Srivastava SK, Antal P, Gál J, Hullám G, Semsei ÁF, Gy Nagy, et al. Lack of evidence for association of two functional SNPs of CHI3L1 gene(HC-gp39) with rheumatoid arthritis. Rheumatol. Int. 2010;Epub ahead of print Mar 19 doi:10.1007/s00296-010-1396
  20. Svensson A, Tagerud S. Galectin-1 expression in innervated and denervated skeletal muscle. Cell. Mol. Biol. Lett. 2009;14:128–138
  21. Villalobo A, Nogales-Gonzalés A, Gabius H-J. A guide to signaling pathways connecting protein–glycan interaction with the emerging versatile effector functionality of mammalian lectins. Trends Glycosci Glycotechnol. 2006;18(99):1–37
  22. Wang J, Lu ZH, Gabius H-J, Rohowsky-Kochan C, Ledeen RW, Wu G. Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J. Immunol. 2009;182(7):4036–4045
  23. Wellcome Trust Case Control Consortium. Genome-wide association study of 14, 000 cases of seven common diseases and 3, 000 shared controls. Nature. 2007;447:661–678
  24. Wigginton JE, Cutler DJ, Abecasis GR. A note on exact tests of Hardy–Weinberg equilibrium. Am. J. Hum. Genet. 2005;76:887–893

PII: S0165-5728(10)00328-0

doi: 10.1016/j.jneuroim.2010.07.015

Journal of Neuroimmunology
Volume 229, Issue 1 , Pages 107-111 , 15 December 2010

Article Tools

* Image Usage & Resolution